Stay updated with breaking news from Bioscience Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The recombinant proteins market size is expected to grow by USD 650.96 million from 2022 to 2027 at a CAGR of 9.46%, as per the latest...
31.05.2023 - The Concept Elicitation Study Informed the Selection of the Primary, Secondary, and Exploratory Endpoints Included in the Phase 2b RESPOND Clinical Study Evaluating the Efficacy and Safety of Sildenafil Cream, 3.6% in Premenopausal Patients with ... Seite 1
Daré Bioscience (NASDAQ:DARE – Get Rating) and Apellis Pharmaceuticals (NASDAQ:APLS – Get Rating) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings and risk. Analyst Recommendations This is a breakdown of recent recommendations and […]
Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) was the recipient of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 378,600 shares, a decrease of 25.9% from the April 30th total of 511,000 shares. Based on an average daily volume of 191,300 shares, the […]
Yield10 Bioscience, Inc. (NASDAQ:YTEN – Get Rating) was the target of a large decrease in short interest during the month of May. As of May 15th, there was short interest totalling 78,000 shares, a decrease of 27.8% from the April 30th total of 108,000 shares. Approximately 2.0% of the company’s shares are short sold. Based […]